Platelet-Rich Plasma (PRP) for Knee Osteoarthritis

By: Dr Zaid Matti
Musculoskeletal Medicine Specialist

Evidence-Based Treatment in 2026: What Patients and Clinicians Should Know

Knee osteoarthritis is one of the most common causes of chronic pain worldwide and a leading reason patients seek specialist musculoskeletal care. Historically, treatment options sat between two unsatisfactory extremes: short-term symptom relief injections, or major joint replacement surgery.

Today, platelet-rich plasma (PRP) is emerging as a scientifically supported biological treatment capable of improving pain, function, and possibly disease progression in appropriately selected patients.

Recent international clinical guidance released by the American Academy of Physical Medicine and Rehabilitation (AAPM&R) confirms PRP is now a recommended option for patients with persistent symptoms after conservative care.

This article explains what PRP is, who benefits most, how modern protocols work, and why injection technique and platelet dose matter.

🦴 Understanding Knee Osteoarthritis Properly

Many patients are told osteoarthritis is simply “wear and tear cartilage damage.” This explanation is incomplete.

Knee osteoarthritis is a whole-joint disease involving:

Cartilage
Subchondral bone
Synovium
Ligaments
Menisci
Surrounding muscles

Modern MRI research demonstrates that bone marrow lesions and subchondral inflammation strongly correlate with pain severity — which is why advanced biological treatments increasingly target the entire joint environment, not cartilage alone.

🧬 What Is Platelet-Rich Plasma (PRP)?

PRP is a concentration of a patient’s own platelets, prepared from a blood sample using a centrifuge. Platelets contain powerful biological mediators including:

PDGF (platelet-derived growth factor)
TGF-β
VEGF
IGF-1
Anti-inflammatory cytokines

These regulate inflammation, tissue repair, angiogenesis, stem-cell signalling, and cartilage homeostasis.

Instead of suppressing symptoms temporarily — as corticosteroids do — PRP aims to restore healthier joint biology.

⚙️ Why PRP Works in Osteoarthritis

PRP affects several disease mechanisms simultaneously:

1. Reduces inflammation PRP modulates synovial cytokines and suppresses the inflammatory mediators responsible for pain.

2. Supports cartilage cell metabolism Laboratory studies show PRP stimulates chondrocyte activity and extracellular matrix production.

3. Improves subchondral bone signalling Modern evidence confirms osteoarthritis pain frequently originates from bone marrow inflammation, not cartilage alone.

4. Enhances the joint lubrication environment PRP improves synovial fluid composition and joint surface protection.

Clinical systematic reviews consistently demonstrate improvements in pain, walking ability, stiffness, and quality of life compared with corticosteroid or hyaluronic acid injections.

👤 Who Benefits Most from PRP?

The strongest evidence supports PRP for:

Mild osteoarthritis Early cartilage change with intermittent swelling and activity-related pain.

Moderate osteoarthritis Persistent symptoms with structural change but preserved joint space.

The AAPM&R recommends PRP particularly when symptoms persist despite physiotherapy, activity modification, weight optimisation, and oral medications. Earlier treatment appears to produce better outcomes.

📈 Platelet Dose Matters More Than Injection Number

One of the most important scientific developments in PRP therapy is recognition that total platelet dose influences treatment success.

Recent meta-analysis data confirm that higher platelet delivery produces stronger clinical improvement. Modern biologic protocols aim for approximately:

≥ 10 billion platelets per treatment (when clinically appropriate)

Historically, most clinics did not measure platelet dose at all. This is changing rapidly.

🎯 Ultrasound Guidance Improves Accuracy and Outcomes

PRP injections should be performed using ultrasound guidance. Benefits include:

Precise joint entry
Avoidance of cartilage injury during needle placement
Improved treatment distribution within the joint
Safer needle positioning near neurovascular structures
Higher success rates in published comparative studies

Blind landmark injections are increasingly considered outdated practice in regenerative medicine.

🖥️ MRI-Guided Treatment Planning Is the Future

Not all osteoarthritis is the same. MRI helps identify the dominant pain generator and guides a more precise treatment strategy:

MRI Finding	Treatment Strategy
Synovitis	Intra-articular PRP
Bone marrow lesions	Intra-osseous PRP
Effusion	Aspiration + PRP
Meniscal degeneration	Targeted biologic support

Modern international guidance now supports combining intra-articular and intra-osseous PRP in selected patients with subchondral bone involvement. This represents a major shift in osteoarthritis treatment strategy.

🔬 Leukocyte-Rich vs Leukocyte-Poor PRP

Patients often ask which type of PRP is better. Current evidence shows both formulations are effective for knee osteoarthritis. Selection depends on:

Inflammation pattern
Joint environment
Individual treatment goals

Scientific reviews confirm meaningful improvements with either formulation — the more important variables are platelet dose, delivery accuracy, and timing.

⚖️ PRP vs Corticosteroid Injections

	Corticosteroid	PRP
Onset	Rapid	Slower
Duration	Short	Sustained
Cartilage safety	⚠️ Potential toxicity with repeated use	✔️ No toxicity risk
Biological repair	✘	✔️
Functional recovery	Limited	Improved

Meta-analyses show PRP provides sustained improvement beyond 6–12 months compared with steroid injections.

⚖️ PRP vs Hyaluronic Acid (Gel Injections)

Hyaluronic acid aims to improve lubrication. PRP aims to improve biology.

Systematic reviews demonstrate PRP often produces:

Stronger pain reduction
Better function scores
Longer durability of response

💉 How the Procedure Works

Step 1 — Blood collection A small blood sample is taken from the arm.

Step 2 — Centrifugation Platelets are concentrated using a medical-grade centrifuge.

Step 3 — Ultrasound-guided injection PRP is injected precisely into the knee joint under real-time imaging. If fluid is present, joint aspiration prior to injection improves treatment effectiveness.

🕐 What Patients Should Expect After Treatment

Common short-term responses include temporary soreness, mild swelling, and stiffness lasting several days. These are normal biological activation responses, not signs of a problem.

Improvement typically begins within 2–6 weeks
Maximum benefit often occurs between 3–6 months

🔄 When PRP Alone May Not Be Enough

Advanced osteoarthritis sometimes requires combined approaches. Examples include:

Intra-osseous PRP for bone marrow lesions
Adipose-derived cell therapy for advanced joint degeneration
Structured rehabilitation addressing load and biomechanics
Alignment correction strategies where mechanical axis contributes

Modern regenerative medicine increasingly uses precision phenotype-based treatment selection, not single-injection solutions.

✅ Safety Profile of PRP

Because PRP uses the patient’s own blood, serious complications are rare.

Compared with corticosteroid injections: PRP avoids cartilage toxicity risk
Compared with surgery: PRP avoids anaesthesia and recovery risks
No risk of disease transmission or allergic reaction to a foreign substance

⚠️ The Most Common Reasons PRP Fails

PRP effectiveness depends heavily on technique and patient selection. Common causes of poor outcomes include:

Low platelet dose — below the biological threshold for effect
Incorrect injection location — missing the primary pain generator
Failure to aspirate effusion — diluting the injected product
Continued NSAID use around treatment time — blunting the biological response
Late-stage bone collapse — structural change beyond what biologic therapy can address

Modern protocol design addresses each of these factors.

🔭 The Future of Knee Osteoarthritis Treatment

The direction of musculoskeletal medicine is shifting toward precision biologic therapy. Instead of treating osteoarthritis as a single disease, clinicians increasingly classify patients by:

MRI phenotype
Joint biology and inflammation pattern
Mechanical loading environment

PRP is now a central component of this approach — and for many patients, a meaningful alternative to the traditional extremes of steroid injections or surgery.

📋 Key Take-Home Messages

PRP is supported by modern international clinical guidance (AAPM&R, 2026)
It is most effective in mild–moderate osteoarthritis
Platelet dose influences results — higher doses produce stronger outcomes
Ultrasound guidance improves treatment accuracy
MRI helps personalise treatment strategy
Subchondral bone targeting is emerging as a major advance in care

📚 References

American Academy of Physical Medicine and Rehabilitation. PRP Guidance Statement for Knee Osteoarthritis. AAPM&R, 2026. www.aapmr.org
Hooper et al. Platelet dose–response meta-analysis in knee osteoarthritis PRP. 2025.
Dai et al. Randomised trial meta-analysis: PRP versus controls in knee OA. 2025.
Narrative review of 40 high-quality PRP knee OA studies. 2025.
Bansal et al. Platelet dose importance in PRP outcomes. 2025.